Live feed
Filing
SC 13D
SC 13D0001144204-17-029846·Checkpoint Therapeutics, Inc.
Schedule 13D ownership disclosure
Checkpoint Therapeutics, Inc.
Security class unavailable · CUSIP: 162828107
Event date: 2017-03-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-029846
- Form type
- SC 13D
- Filer
- Checkpoint Therapeutics, Inc.
- CIK
- CIK 1651407
- Filed
- May 26, 2017
- Reporting period
- Mar 17, 2017
- Description
- Schedule 13D beneficial ownership